Kaskela Law LLC Announces Stockholder Investigation of Trevi Therapeutics, Inc. - TRVI

In this article:

PHILADELPHIA, PA / ACCESSWIRE / October 31, 2020 / Kaskela Law LLC, announces that it is investigating Trevi Therapeutics, Inc. ("Trevi") (NASDAQ:TRVI) on behalf of the company's stockholders.

The investigation seeks to determine whether Trevi and/or the company's officers and directors have violated the securities laws or breached their fiduciary duties and whether Trevi investors have been harmed as a result of such actions.

Trevi stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585 or (888) 715 - 1740, or via email at skaskela@kaskelalaw.com, to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/trevi-therapeutics-inc/.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC, please visit www.kaskelalaw.com.

CONTACT:
D. Seamus Kaskela, Esq.

KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258-1585
(888) 715-1740
skaskela@kaskelalaw.com
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

SOURCE: Kaskela Law LLC



View source version on accesswire.com:
https://www.accesswire.com/613656/Kaskela-Law-LLC-Announces-Stockholder-Investigation-of-Trevi-Therapeutics-Inc--TRVI

Advertisement